Curs BNR — 12.11.2026 EUR 5,3459 USD 4,8155 GBP 6,3935

BIOFARM

96 articole · RSS

Pharmaceutical Manufacturer Biofarm Earmarks EUR10M for Investments in 2021
Health

Pharmaceutical Manufacturer Biofarm Earmarks EUR10M for Investments in 2021

Pharmaceutical manufacturer Biofarm (BIO.RO) has budgeted RON47.4 million (almost EUR10 million) for investments in 2021, most of which or about 70% will go towards equipping the new product...

Loredana Frățilă-Cristescu · 29.04.2021 · 10:13 · 1 min
Biofarm Cleared for RON21.7M Dividend Payout
Capital Market

Biofarm Cleared for RON21.7M Dividend Payout

Shareholders of Romanian pharmaceutical company Biofarm Bucuresti (BIO.RO) on Monday approved the company's plans to distribute dividends totaling RON21.7 million.

Oana Gavrila · 26.04.2021 · 17:44 · 1 min
Biofarm Targets 15% Growth in Turnover in 2021, to RON250M
Capital Market

Biofarm Targets 15% Growth in Turnover in 2021, to RON250M

Romanian pharmaceutical company Biofarm Bucuresti (BIO.RO) estimates its turnover will grow 15% in 2021 compared with 2020, to over RON250 million.

Oana Gavrila · 23.03.2021 · 10:58 · 1 min
Biofarm Net Profit Up 7.2% To RON54M, Sales Revenue Up 8% To RON218M YoY In 2020
Companies

Biofarm Net Profit Up 7.2% To RON54M, Sales Revenue Up 8% To RON218M YoY In 2020

Biofarm Bucuresti (BIO.RO), one of the leading drugmakers in Romania, ended 2020 with a net profit of RON54.5 million, up 7.2% versus 2019, while income from sales grew 8% to RON218 million,...

Ecaterina Craciun · 16.02.2021 · 10:35 · 1 min
Marian Buica Elected Temporary Member Of Biofarm Board Of Directors
Companies

Marian Buica Elected Temporary Member Of Biofarm Board Of Directors

Marian Buica, general manager of regional investment fund SIF Muntenia (SIF4.RO), was elected temporary member of the Board of Directors of pharmaceuticals company Biofarm, Bucuresti and is...

Ecaterina Craciun · 18.09.2020 · 18:51 · 1 min
Biofarm Posts RON30M Net Profit in H1
Capital Market

Biofarm Posts RON30M Net Profit in H1

Pharmaceutical company Biofarm Bucuresti (BIO.RO) posted 29.8 million lei net profit in the first half, 6% higher than in the year-ago period, while revenue stood at RON106 million, up from...

Loredana Frățilă-Cristescu · 17.08.2020 · 09:40 · 1 min
Biofarm Seeks To Pay Gross Dividends Of RON0.021/Share From 2019 Net Profit, At 6.3% Yield
Health

Biofarm Seeks To Pay Gross Dividends Of RON0.021/Share From 2019 Net Profit, At 6.3% Yield

The Board of Directors of Biofarm Bucuresti (BIO), one of the largest pharmaceuticals producers in Romania, has summoned its shareholders on April 28, 2020 to submit for approval the distrib...

Ecaterina Craciun · 24.03.2020 · 15:12 · 1 min
Biofarm Shareholders Approve Additional Dividends of RON9.8M
Capital Market

Biofarm Shareholders Approve Additional Dividends of RON9.8M

Shareholders of pharmaceutical producer Biofarm (BIO.RO) on Wednesday approved additional dividends of RON0.01 per share, amounting to RON9.8 million.

Oana Gavrila · 11.12.2019 · 17:43 · 1 min
Biofarm Investments Exceed RON10M In January-June 2019
Companies

Biofarm Investments Exceed RON10M In January-June 2019

Romanian pharmaceutical producer Biofarm (BIO.RO) on Wednesday reported sales revenue of RON97.2 million in the first half of 2019, up 17% from the year-earlier period.

Ecaterina Craciun · 14.08.2019 · 14:32 · 1 min